Highland Investment Advisors LLC’s AstraZeneca AZN Stock Holding History

Highland Investment Advisors LLC’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$76.7K	Buy	+404	New	+$76K	0.03%	142

Other funds holding AZN

EPGL

Evelyn Partners Group Ltd London $46.9B AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $148B AUM

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Highland Investment Advisors LLC's AZN Position: Q2 2026 in Review

Highland Investment Advisors LLC opened a new position in AstraZeneca (AZN) in Q2 2026: 404 shares worth $76.7K. The stake represents 0.03% of the portfolio and ranks #142 among its holdings.

1,250 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Highland Investment Advisors LLC held 404 shares of AstraZeneca worth $76.7K as of Q2 2026.
AstraZeneca was a new Highland Investment Advisors LLC position in Q2 2026.
AstraZeneca made up 0.03% of Highland Investment Advisors LLC's portfolio in Q2 2026, its #142 holding.
1,250 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Highland Investment Advisors LLC's 13F filing for Q2 2026, filed 13 Aug 2026.